Disufenton sodium (English Wikipedia)

Analysis of information sources in references of the Wikipedia article "Disufenton sodium" in English language version.

refsWebsite

Global rank English rank

14nih.gov

4^th place

10doi.org

2^nd place

3semanticscholar.org

11^th place

8^th place

2harvard.edu

18^th place

17^th place

1web.archive.org

1^st place

1renovis.com

low place

1healio.com

low place

1worldcat.org

5^th place

1army.mil

249^th place

169^th place

1okcfox.com

low place

army.mil

cdmrp.army.mil

"Congressionally Directed Medical Research Programs (CDMRP) Search Awards". Congressionally Directed Medical Research Programs. Retrieved February 5, 2022.

doi.org

Varela-Nieto I, Murillo-Cuesta S, Rodríguez-de la Rosa L, Oset-Gasque MJ, Marco-Contelles J (September 1, 2021). "Use of Radical Oxygen Species Scavenger Nitrones to Treat Oxidative Stress-Mediated Hearing Loss: State of the Art and Challenges". Frontiers in Cellular Neuroscience. 15. Frontiers Media SA: 711269. doi:10.3389/fncel.2021.711269. PMC 8440819. PMID 34539349.
Zhao Z, Cheng M, Maples KR, Ma JY, Buchan AM (August 2001). "NXY-059, a novel free radical trapping compound, reduces cortical infarction after permanent focal cerebral ischemia in the rat". Brain Research. 909 (1–2). Elsevier BV: 46–50. doi:10.1016/s0006-8993(01)02618-x. PMID 11478919. S2CID 36633423.
Choi SH, Choi CH (December 2015). "Noise-Induced Neural Degeneration and Therapeutic Effect of Antioxidant Drugs". Journal of Audiology & Otology. 19 (3). The Korean Audiological Society: 111–119. doi:10.7874/jao.2015.19.3.111. PMC 4704551. PMID 26771008.
Lees KR, Zivin JA, Ashwood T, Davalos A, Davis SM, Diener HC, et al. (February 2006). "NXY-059 for acute ischemic stroke". The New England Journal of Medicine. 354 (6): 588–600. doi:10.1056/NEJMoa052980. PMID 16467546.
Lees KR, Davalos A, Davis SM, Diener HC, Grotta J, Lyden P, et al. (December 2006). "Additional outcomes and subgroup analyses of NXY-059 for acute ischemic stroke in the SAINT I trial". Stroke. 37 (12): 2970–2978. doi:10.1161/01.STR.0000249410.91473.44. PMID 17068304.
Thomas L, Smith N, Saunders D, Zalles M, Gulej R, Lerner M, et al. (November 2020). "OKlahoma Nitrone-007: novel treatment for diffuse intrinsic pontine glioma". Journal of Translational Medicine. 18 (1). Springer Science and Business Media LLC: 424. doi:10.1186/s12967-020-02593-5. PMC 7654606. PMID 33168005.
Battiste JD, Ikeguchi A, Woo S, Sharan S, Zhao YD, Cohoon A, et al. (May 20, 2020). "Phase Ib clinical trial of OKN-007 in recurrent malignant glioma". Journal of Clinical Oncology. 38 (15_suppl). American Society of Clinical Oncology (ASCO): 2538. doi:10.1200/jco.2020.38.15_suppl.2538. ISSN 0732-183X. S2CID 219772612.
Zalles M, Smith N, Saunders D, Lerner M, Fung KM, Battiste J, Towner RA (January 2022). "A tale of two multi-focal therapies for glioblastoma: An antibody targeting ELTD1 and nitrone-based OKN-007". Journal of Cellular and Molecular Medicine. 26 (2). Wiley: 570–582. doi:10.1111/jcmm.17133. PMC 8743651. PMID 34910361.
Lu J, West MB, Du X, Cai Q, Ewert DL, Cheng W, et al. (January 7, 2021). Biagini G (ed.). "Electrophysiological assessment and pharmacological treatment of blast-induced tinnitus". PLOS ONE. 16 (1). Public Library of Science (PLoS)\: e0243903. Bibcode:2021PLoSO..1643903L. doi:10.1371/journal.pone.0243903. PMC 7790300. PMID 33411811.
Zhang J (November 2019). "Blast-induced tinnitus: Animal models". The Journal of the Acoustical Society of America. 146 (5). Acoustical Society of America (ASA): 3811–3831. Bibcode:2019ASAJ..146.3811Z. doi:10.1121/1.5132551. PMID 31795642. S2CID 208621727.

harvard.edu

ui.adsabs.harvard.edu

Lu J, West MB, Du X, Cai Q, Ewert DL, Cheng W, et al. (January 7, 2021). Biagini G (ed.). "Electrophysiological assessment and pharmacological treatment of blast-induced tinnitus". PLOS ONE. 16 (1). Public Library of Science (PLoS)\: e0243903. Bibcode:2021PLoSO..1643903L. doi:10.1371/journal.pone.0243903. PMC 7790300. PMID 33411811.
Zhang J (November 2019). "Blast-induced tinnitus: Animal models". The Journal of the Acoustical Society of America. 146 (5). Acoustical Society of America (ASA): 3811–3831. Bibcode:2019ASAJ..146.3811Z. doi:10.1121/1.5132551. PMID 31795642. S2CID 208621727.

healio.com

"FDA grants fast track status to OKN-007 for diffuse intrinsic pontine glioma". Healio. March 3, 2021. Retrieved February 5, 2022.

nih.gov

pubmed.ncbi.nlm.nih.gov

Varela-Nieto I, Murillo-Cuesta S, Rodríguez-de la Rosa L, Oset-Gasque MJ, Marco-Contelles J (September 1, 2021). "Use of Radical Oxygen Species Scavenger Nitrones to Treat Oxidative Stress-Mediated Hearing Loss: State of the Art and Challenges". Frontiers in Cellular Neuroscience. 15. Frontiers Media SA: 711269. doi:10.3389/fncel.2021.711269. PMC 8440819. PMID 34539349.
Zhao Z, Cheng M, Maples KR, Ma JY, Buchan AM (August 2001). "NXY-059, a novel free radical trapping compound, reduces cortical infarction after permanent focal cerebral ischemia in the rat". Brain Research. 909 (1–2). Elsevier BV: 46–50. doi:10.1016/s0006-8993(01)02618-x. PMID 11478919. S2CID 36633423.
Choi SH, Choi CH (December 2015). "Noise-Induced Neural Degeneration and Therapeutic Effect of Antioxidant Drugs". Journal of Audiology & Otology. 19 (3). The Korean Audiological Society: 111–119. doi:10.7874/jao.2015.19.3.111. PMC 4704551. PMID 26771008.
Lees KR, Zivin JA, Ashwood T, Davalos A, Davis SM, Diener HC, et al. (February 2006). "NXY-059 for acute ischemic stroke". The New England Journal of Medicine. 354 (6): 588–600. doi:10.1056/NEJMoa052980. PMID 16467546.
Lees KR, Davalos A, Davis SM, Diener HC, Grotta J, Lyden P, et al. (December 2006). "Additional outcomes and subgroup analyses of NXY-059 for acute ischemic stroke in the SAINT I trial". Stroke. 37 (12): 2970–2978. doi:10.1161/01.STR.0000249410.91473.44. PMID 17068304.
Thomas L, Smith N, Saunders D, Zalles M, Gulej R, Lerner M, et al. (November 2020). "OKlahoma Nitrone-007: novel treatment for diffuse intrinsic pontine glioma". Journal of Translational Medicine. 18 (1). Springer Science and Business Media LLC: 424. doi:10.1186/s12967-020-02593-5. PMC 7654606. PMID 33168005.
Zalles M, Smith N, Saunders D, Lerner M, Fung KM, Battiste J, Towner RA (January 2022). "A tale of two multi-focal therapies for glioblastoma: An antibody targeting ELTD1 and nitrone-based OKN-007". Journal of Cellular and Molecular Medicine. 26 (2). Wiley: 570–582. doi:10.1111/jcmm.17133. PMC 8743651. PMID 34910361.
Lu J, West MB, Du X, Cai Q, Ewert DL, Cheng W, et al. (January 7, 2021). Biagini G (ed.). "Electrophysiological assessment and pharmacological treatment of blast-induced tinnitus". PLOS ONE. 16 (1). Public Library of Science (PLoS)\: e0243903. Bibcode:2021PLoSO..1643903L. doi:10.1371/journal.pone.0243903. PMC 7790300. PMID 33411811.
Zhang J (November 2019). "Blast-induced tinnitus: Animal models". The Journal of the Acoustical Society of America. 146 (5). Acoustical Society of America (ASA): 3811–3831. Bibcode:2019ASAJ..146.3811Z. doi:10.1121/1.5132551. PMID 31795642. S2CID 208621727.

ncbi.nlm.nih.gov

Varela-Nieto I, Murillo-Cuesta S, Rodríguez-de la Rosa L, Oset-Gasque MJ, Marco-Contelles J (September 1, 2021). "Use of Radical Oxygen Species Scavenger Nitrones to Treat Oxidative Stress-Mediated Hearing Loss: State of the Art and Challenges". Frontiers in Cellular Neuroscience. 15. Frontiers Media SA: 711269. doi:10.3389/fncel.2021.711269. PMC 8440819. PMID 34539349.
Choi SH, Choi CH (December 2015). "Noise-Induced Neural Degeneration and Therapeutic Effect of Antioxidant Drugs". Journal of Audiology & Otology. 19 (3). The Korean Audiological Society: 111–119. doi:10.7874/jao.2015.19.3.111. PMC 4704551. PMID 26771008.
Thomas L, Smith N, Saunders D, Zalles M, Gulej R, Lerner M, et al. (November 2020). "OKlahoma Nitrone-007: novel treatment for diffuse intrinsic pontine glioma". Journal of Translational Medicine. 18 (1). Springer Science and Business Media LLC: 424. doi:10.1186/s12967-020-02593-5. PMC 7654606. PMID 33168005.
Zalles M, Smith N, Saunders D, Lerner M, Fung KM, Battiste J, Towner RA (January 2022). "A tale of two multi-focal therapies for glioblastoma: An antibody targeting ELTD1 and nitrone-based OKN-007". Journal of Cellular and Molecular Medicine. 26 (2). Wiley: 570–582. doi:10.1111/jcmm.17133. PMC 8743651. PMID 34910361.
Lu J, West MB, Du X, Cai Q, Ewert DL, Cheng W, et al. (January 7, 2021). Biagini G (ed.). "Electrophysiological assessment and pharmacological treatment of blast-induced tinnitus". PLOS ONE. 16 (1). Public Library of Science (PLoS)\: e0243903. Bibcode:2021PLoSO..1643903L. doi:10.1371/journal.pone.0243903. PMC 7790300. PMID 33411811.

okcfox.com

Martin B (July 27, 2020). "Hough Ear Institute receives $300K grant to support research treatments for hearing loss". KOKH. Retrieved February 5, 2022.

renovis.com

investors.renovis.com

"Renovis: Press Release". Archived from the original on October 28, 2006.

semanticscholar.org

api.semanticscholar.org

Zhao Z, Cheng M, Maples KR, Ma JY, Buchan AM (August 2001). "NXY-059, a novel free radical trapping compound, reduces cortical infarction after permanent focal cerebral ischemia in the rat". Brain Research. 909 (1–2). Elsevier BV: 46–50. doi:10.1016/s0006-8993(01)02618-x. PMID 11478919. S2CID 36633423.
Battiste JD, Ikeguchi A, Woo S, Sharan S, Zhao YD, Cohoon A, et al. (May 20, 2020). "Phase Ib clinical trial of OKN-007 in recurrent malignant glioma". Journal of Clinical Oncology. 38 (15_suppl). American Society of Clinical Oncology (ASCO): 2538. doi:10.1200/jco.2020.38.15_suppl.2538. ISSN 0732-183X. S2CID 219772612.
Zhang J (November 2019). "Blast-induced tinnitus: Animal models". The Journal of the Acoustical Society of America. 146 (5). Acoustical Society of America (ASA): 3811–3831. Bibcode:2019ASAJ..146.3811Z. doi:10.1121/1.5132551. PMID 31795642. S2CID 208621727.

web.archive.org

"Renovis: Press Release". Archived from the original on October 28, 2006.

worldcat.org

Battiste JD, Ikeguchi A, Woo S, Sharan S, Zhao YD, Cohoon A, et al. (May 20, 2020). "Phase Ib clinical trial of OKN-007 in recurrent malignant glioma". Journal of Clinical Oncology. 38 (15_suppl). American Society of Clinical Oncology (ASCO): 2538. doi:10.1200/jco.2020.38.15_suppl.2538. ISSN 0732-183X. S2CID 219772612.